Report Detail

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Extended Release Drug Market Status and Forecast (2016-2027)
      • 1.3.2 Global Extended Release Drug Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Extended Release Drug Supply by Company

    • 2.1 Global Extended Release Drug Sales Value by Company
    • 2.2 Extended Release Drug Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional Extended Release Drug Market Status by Category

    • 3.1 Extended Release Drug Category Introduction
      • 3.1.1 Sustained Release Drug
      • 3.1.2 Controlled Release Drug
    • 3.2 Global Extended Release Drug Market by Category
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Extended Release Drug Market Status by End User/Segment

    • 4.1 Extended Release Drug Segment by End User/Segment
      • 4.1.1 Hospital Pharmacy
      • 4.1.2 Retail Pharmacy
      • 4.1.3 Online Pharmacy
    • 4.2 Global Extended Release Drug Market by End User/Segment
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Extended Release Drug Market Status by Region

    • 5.1 Global Extended Release Drug Market by Region
    • 5.2 North America Extended Release Drug Market Status
    • 5.3 Europe Extended Release Drug Market Status
    • 5.4 Asia Pacific Extended Release Drug Market Status
    • 5.5 Central & South America Extended Release Drug Market Status
    • 5.6 Middle East & Africa Extended Release Drug Market Status

    6 North America Extended Release Drug Market Status

    • 6.1 North America Extended Release Drug Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Extended Release Drug Market Status

    • 7.1 Europe Extended Release Drug Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Extended Release Drug Market Status

    • 8.1 Asia Pacific Extended Release Drug Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Extended Release Drug Market Status

    • 9.1 Central & South America Extended Release Drug Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Extended Release Drug Market Status

    • 10.1 Middle East & Africa Extended Release Drug Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global Extended Release Drug Market Forecast by Category and by End User/Segment

    • 12.1 Global Extended Release Drug Sales Value Forecast (2022-2027)
    • 12.2 Global Extended Release Drug Forecast by Category
    • 12.3 Global Extended Release Drug Forecast by End User/Segment

    13 Global Extended Release Drug Market Forecast by Region/Country

    • 13.1 Global Extended Release Drug Market Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Teva
      • 14.1.1 Company Information
      • 14.1.2 Extended Release Drug Product Introduction
      • 14.1.3 Teva Extended Release Drug Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Sun Pharmaceutical Industries
      • 14.2.1 Company Information
      • 14.2.2 Extended Release Drug Product Introduction
      • 14.2.3 Sun Pharmaceutical Industries Extended Release Drug Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Purdue Pharma
      • 14.3.1 Company Information
      • 14.3.2 Extended Release Drug Product Introduction
      • 14.3.3 Purdue Pharma Extended Release Drug Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Pfizer
      • 14.4.1 Company Information
      • 14.4.2 Extended Release Drug Product Introduction
      • 14.4.3 Pfizer Extended Release Drug Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Mylan
      • 14.5.1 Company Information
      • 14.5.2 Extended Release Drug Product Introduction
      • 14.5.3 Mylan Extended Release Drug Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Mallinckrodt
      • 14.6.1 Company Information
      • 14.6.2 Extended Release Drug Product Introduction
      • 14.6.3 Mallinckrodt Extended Release Drug Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Johnson & Johnson
      • 14.7.1 Company Information
      • 14.7.2 Extended Release Drug Product Introduction
      • 14.7.3 Johnson & Johnson Extended Release Drug Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Hisamitsu Pharmaceutical
      • 14.8.1 Company Information
      • 14.8.2 Extended Release Drug Product Introduction
      • 14.8.3 Hisamitsu Pharmaceutical Extended Release Drug Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Endo Pharmaceuticals
      • 14.9.1 Company Information
      • 14.9.2 Extended Release Drug Product Introduction
      • 14.9.3 Endo Pharmaceuticals Extended Release Drug Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.9.4 SWOT Analysis

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Extended Release Drug market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Extended Release Drug market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Sustained Release Drug
      Controlled Release Drug

      Segmented by End User/Segment
      Hospital Pharmacy
      Retail Pharmacy
      Online Pharmacy

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Teva
      Sun Pharmaceutical Industries
      Purdue Pharma
      Pfizer
      Mylan
      Mallinckrodt
      Johnson & Johnson
      Hisamitsu Pharmaceutical
      Endo Pharmaceuticals


      Summary:
      Get latest Market Research Reports on Extended Release Drug. Industry analysis & Market Report on Extended Release Drug is a syndicated market report, published as Dynamics in Post-pandemic Global Extended Release Drug Industry: Supply and Demand, Markets and Prices 2021-2027. It is complete Research Study and Industry Analysis of Extended Release Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,980.00
      $4,470.00
      $5,960.00
      2,109.84
      3,164.76
      4,219.68
      2,455.52
      3,683.28
      4,911.04
      326,846.40
      490,269.60
      653,692.80
      218,106.20
      327,159.30
      436,212.40
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report